¨
B. Groll et al.
2-Phenyl-1-(thiophen-3-ylethynyl)-1,2,3,4-tetrahydroiso-
quinoline (13f, C21H17NS)
(PE:EtOAc = 20:1); NMR data were in agreement with
the literature [21].
It was prepared according to General Procedure A (57%,
36 mg, 0.11 mmol) and B (71%, 90 mg, 0.28 mmol). The
product was isolated by column chromatography (PE/
DCM) as a light yellow oil. Rf = 0.49 (PE:EtOAc = 20:1);
1H NMR (200 MHz, CDCl3): d = 2.92–3.28 (m, 2H, H4),
3.55–3.87 (m, 2H, H3), 5.66 (s, 1H, H1), 6.84–7.48 (m,
12H, H5-H8, H20-H40, H200, H300, H400) ppm; 13C NMR
(50 MHz, CDCl3): d = 29.2 (t, C4), 43.7 (t, C3), 52.5 (d,
C1), 80.11 (s, C alkyne), 88.42 (s, C alkyne), 116.9 (d,
C20), 119.9 (d, C40), 122.3 (d, C200), 125.3 (s, C100), 126.6
(d, C7), 127.5 (d, C6), 127.7 (d, C5), 128.9 (d, C300), 129.2
(d, C8), 129.4 (d, C30), 130.3 (d, C400), 134.7 (s, C4a),
135.6 (s, C8a), 149.8 (d, C40) ppm; HR-MS: m/z calculated
[M?H]? 316.1154, found 316.1143.
1-(Octa-1,7-diyn-1-yl)-2-(4-methoxyphenyl)-1,2,3,4-te-
trahydroisoquinoline (14d, C24H25NO)
Prepared according to General Procedure A (25%, 17 mg,
0.05 mmol). The product was isolated by preparative TLC
(CHCl3) as
a
light yellow oil. Rf = 0.30 (PE:E-
1H
NMR (200 MHz, CDCl3):
tOAc = 20:1);
d = 1.48–1.57 (m, 4H, Alkyl-CH2), 1.99–2.02 (m, 1H,
alkyne-CH), 2.13–2.29 (m, 4H, alkyl-CH2), 2.88–3.30 (m,
2H, TIQ-CH2), 3.52–3.65 (m, 2H, TIQ-CH2), 3.88 (s, 3H,
OCH3), 5.38 (s, 1H, TIQ-CH), 6.91–7.40 (m, 8H, Ar–CH)
ppm; 13C NMR (50 MHz, CDCl3): d = 18.2 (t, C400), 18.6
(t, C100), 27.6 (t, C300), 27.9 (t, C200), 29.3 (t, C4), 44.3 (t,
C3), 54.1 (q, OCH3), 55.9 (d, C1), 56.3 (OCH3), 68.7 (C1),
79.7 (s, CA1), 84.6 (d, C600), 85.5 (s, CA2), 94.8 (s, C500),
114.6 (d, C20), 118.4, 120.3 (d, C30), 126.3 (d, C7), 127.2
(d, C6), 127.7 (d, C5), 129.3 (d, C8), 132.6, 134.1 (s, C4a),
136.4 (s, C8a), 144.6 (s, C10), 154.3 (s, C40) ppm; HR-MS:
m/z calculated [M?H]? 344.2009, found 344.2006.
1-(2-Phenylethynyl)-2-(4-methoxyphenyl)-1,2,3,4-tetrahy-
droisoquinoline (14a)
It was prepared according to General Procedure A (42%,
29 mg, 0.08 mmol). The product was isolated by column
chromatography (PE/DCM) as a light yellow oil. Rf = 0.30
(PE:EtOAc = 20:1); NMR data were in agreement with
the literature [21].
1-(Cyclopropylethynyl)-2-(4-methoxyphenyl)-1,2,3,4-te-
trahydroisoquinoline (14e, C21H21NO)
It was prepared according to General Procedure A (93%,
56 mg, 0.19 mmol). The product was isolated by prepar-
1-(Hept-1-yn-1-yl)-2-(4-methoxyphenyl)-1,2,3,4-tetrahy-
droisoquinoline (14b, C23H27NO)
ative TLC (CHCl3) as
a
yellow oil. Rf = 0.31
It was prepared according to General Procedure A (75%,
50 mg, 0.15 mmol). The product was isolated by prepar-
ative TLC (CHCl3) as an orange oil. Rf = 0.31
(PE:EtOAc = 20:1); 1H NMR (200 MHz, CDCl3):
d = 0.83 (t, 3J = 6.4 Hz, 3J = 6.4 Hz, 3H, H500),
(PE:EtOAc = 20:1); 1H NMR (200 MHz, CDCl3):
d = 0.49–0.76 (m, 4H, H200), 1.09–1.26 (m, 1H, C100),
2.84–3.23 (m, 2H, H4), 3.45–3.68 (m, 2H, H3), 3.83 (s, 3H,
3
OCH3), 5.33 (s, 1H, H1), 6.91 (d, J = 9.1 Hz, 2H, H30),
7.08 (d, 3J = 9.1 Hz, 2H, H20), 7.14–7.35 (m, 4H, H5–H8)
ppm; 13C NMR (50 MHz, CDCl3): d = 0.0 (d, C100), 8.6 (t,
C200), 29.2 (t, C4), 44.3 (t, C3), 54.0 (q, OCH3), 55.9 (d,
C1), 74.3 (s, C alkyne), 89.3 (s, C alkyne), 114.5 (d, C20),
120.3 (d, C30), 126.3 (d, C7), 127.2 (d, C6), 127.7 (d, C5),
129.3 (d, C8), 134.1 (s, C4a), 136.4 (s, C8a), 144.5 (s, C10),
154.3 (s, C40) ppm; HR-MS: m/z calculated [M?H]?
304.1696, found 304.1694.
3
1.11–1.45 (m, CH2, 6H, H200–H400), 2.07(dt, J = 6.8 Hz,
3J = 6.9 Hz, 4J = 1.9 Hz, 2H, H100), 2.87 (td,
3J = 16.3 Hz, 4J = 3.5 Hz, 4J = 3.5 Hz, 1H, H4), 3.09
3
4
4
(ddd, J = 16.5 Hz, J = 9.7 Hz, J = 6.8 Hz, 1H, H4),
3.45–3.58 (m, 2H, H3), 3.77 (s, 3H, OCH3), 5.28 (s, 1H,
3
3
H1), 6.86 (d, J = 9.1 Hz, 2H, H30), 7.04 (d, J = 9.1 Hz,
2H, H20), 7.10–7.30 (m, 4H, H5–H8) ppm; 13C NMR
(50 MHz, APT, CDCl3): d = 14.0 (q, C500), 18.7 (t, C100),
22.2 (t, C200), 28.4 (t, C400), 29.0 (t, C4), 30.9 (t, C300), 44.0
(t, C3), 53.8 (q, OCH3), 55.5 (d, C1), 78.9 (s, C alkyne),
86.0 (s, C alkyne), 114.3 (d, C20), 120.0 (d, C30), 126.0 (d,
C7), 126.9 (d, C6), 127.4 (d, C5), 129.0 (d, C8), 133.8 (s,
C4a), 136.3 (s, C8a), 144.3 (s, C10), 154.0 (s, C40) ppm;
HR-MS: m/z calculated [M?H]? 334.2165, found
334.2162.
1-(5-Chloropent-1-yn-1-yl)-2-(4-methoxyphenyl)-1,2,3,4-
tetrahydroisoquinoline (14f, C20H20ClN)
It was prepared according to General Procedure A (52%,
32 mg, 0.10 mmol). The product was isolated by prepar-
ative TLC (CHCl3) as a light yellow oil. Rf = 0.28
(PE:EtOAc = 20:1); 1H NMR (200 MHz, CDCl3):
d = 1.72–1.88 (m, 2H, H200), 2.21–2.35 (m, 2H, H300),
2.81–3.23 (m, 2H, H4), 3.34–3.59 (m, 4H, H3, H100), 3.80
(s, 3H, OCH3), 5.32 (s, 1H, H1), 6.89 (d, 3J = 9.1 Hz, 2H,
1-(Oct-1-yn-1-yl)-2-(4-methoxyphenyl)-1,2,3,4-tetrahy-
droisoquinoline (14c)
3
H30), 7.05 (d, J = 9.1 Hz, 2H, H20), 7.12–7.34 (m, 4H,
It was prepared according to General Procedure A (61%,
42 mg, 0.12 mmol). The product was isolated by prepar-
ative TLC (CHCl3) as a light yellow oil. Rf = 0.35
H5–H8) ppm; 13C NMR (50 MHz, CDCl3): d = 16.5 (t,
C300), 29.3 (t, C4), 31.7 (t, C200), 43.8 (t, C100), 44.3 (t, C3),
54.3 (q, OCH3), 55.9 (d, C1), 77.8 (s, C alkyne), 80.4 (s, C
123